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Fxyd2 regulates Aδ- and C-fiber 
mechanosensitivity and is required 
for the maintenance of neuropathic 
pain
Stéphanie Ventéo1, Sophie Laffray2,3, Christiane Wetzel4, Cyril Rivat1,3, Frédérique Scamps1, 
Ilana Méchaly1,3, Luc Bauchet1,5, Cédric Raoul1, Emmanuel Bourinet2, Gary R. Lewin4, 
Patrick Carroll1,* & Alexandre Pattyn1,*
Identification of the molecular mechanisms governing sensory neuron subtype excitability is a key 
requisite for the development of treatments for somatic sensory disorders. Here, we show that the 
Na,K-ATPase modulator Fxyd2 is specifically required for setting the mechanosensitivity of Aδ-fiber 
low-threshold mechanoreceptors and sub-populations of C-fiber nociceptors, a role consistent with its 
restricted expression profile in the spinal somatosensory system. We also establish using the spared 
nerve injury model of neuropathic pain, that loss of Fxyd2 function, either constitutively in Fxyd2−/− 
mice or acutely in neuropathic rats, efficiently alleviates mechanical hypersensitivity induced by 
peripheral nerve lesions. The role of Fxyd2 in modulating Aδ- and C-fibers mechanosensitivity likely 
accounts for the anti-allodynic effect of Fxyd2 knockdown. Finally, we uncover the evolutionarily 
conserved restricted expression pattern of FXYD2 in human dorsal root ganglia, thus identifying this 
molecule as a potentially promising therapeutic target for peripheral neuropathic pain management.
Molecular, behavioral and electrophysiological analyses of transgenic models have proven to be a powerful 
strategy for dissecting the mechanisms by which functionally diverse subtypes of first order somatosensory 
neurons of the dorsal root ganglia (DRG) respond to nociceptive, thermal, and mechanical stimuli. In parallel, 
growing knowledge of the pathological changes that occur in these neurons in disease states, including chronic 
pain, is driving the development of new treatments for sensory disorders1. Based on their etiology and the cel-
lular and molecular mechanisms involved, chronic pain conditions are classically divided into tissue damage/
inflammation-induced pain and neuropathic pain2. Neuropathic pain is characterized by persistent spontaneous 
pain and/or pain hypersensitivity including allodynia and hyperalgesia, which follows lesions or dysfunction of 
the somatosensory system3,4. Its origins can be multiple, partly explaining why existing treatments are only mod-
erately effective, but generally involve pathological changes in nociceptive and innocuous touch sensing neurons 
leading to persistent modifications in spinal pain processing circuits4,5. Peripheral nerve damage represents a 
major cause of neuropathic pain which alters the electrophysiological properties of primary sensory axons, not 
only of injured axons but also of neighboring sensitized non-injured fibers6–8. The excitability changes that follow 
nerve injury may be due to alterations of the expression, distribution and/or biophysical properties of various 
ion channels that are essential for the maintenance of normal sensory neuron excitability3–5,9. Previously, we and 
others have reported that the expression of the Fxyd2 gene encoding the gamma subunit of the Na,K-ATPase 
pump10,11 is induced postnatally and restricted in adulthood to specific neuronal subtypes of DRG neurons12–14. 
Recently Fxyd2 has been shown to modulate the activity of the α 1-catalytic subunit of the Na,K-ATPase in 
non-peptidergic nociceptors and to play a role in inflammatory pain13. Here, by examining in detail the function 
1INSERM U1051, Institut des Neurosciences de Montpellier, Hôpital St Eloi, 80 rue Augustin Fliche, 34091 
Montpellier, France. 2UMR5203, INSERM U1191, Institut de Génomique Fonctionnelle, 141 rue de la Cardonille, 
34094 Montpellier, France. 3Université de Montpellier, Place Eugène Bataillon, 34090 Montpellier, France. 
4Department of Neuroscience, Max-Delbrück Center for Molecular Medicine, Robert-Rössle Str. 10, D-13125 
Berlin, Germany. 5Département de Neurochirurgie, Hôpital Gui de Chauliac, CHU, 80 avenue Augustin Fliche, 34295 
Montpellier, France. *These authors contributed equally to this work. Correspondence and requests for materials 
should be addressed to A.P. (email: alexandre.pattyn@inserm.fr)
received: 17 June 2016
Accepted: 12 October 2016
Published: 02 November 2016
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 6:36407 | DOI: 10.1038/srep36407
of Fxyd2 in neurochemically and physiologically defined subtypes of sensory neurons on ex vivo skin-saphenous 
nerve preparations of Fxyd2−/− mutant mice, we reveal that Fxyd2 is specifically required to maintain normal 
transduction properties of both C-fiber nociceptor populations and Aδ -fiber low-threshold mechanoreceptors 
(LTMRs) termed D-Hair receptors. Moreover, by assessing the implication of Fxyd2 in the pathogenesis of neuro-
pathic pain, we establish that this gene contributes to pain chronification. Indeed, we report that Fxyd2−/− mutant 
mice fail to maintain mechanical allodynia over time in the spared nerve injury model of neuropathic pain. We 
additionally provide the proof of concept that acute injections of Fxyd2-siRNA in neuropathic rats efficiently 
alleviate pain hypersensitivity induced by peripheral nerve lesions. Finally, we uncover the evolutionarily con-
served restricted expression of FXYD2 in human DRG, thus identifying this molecule as a potentially promising 
therapeutic target for peripheral neuropathic pain management.
Results and Discussion
In the spinal somatosensory system, Fxyd2 displays a restricted expression profile in specific classes of primary 
sensory neurons of the DRG, including the TrkB-positive (+ ) D-Hair Aδ -fiber LTMRs and the IB4+ C-fiber 
non-peptidergic nociceptors, but is absent from second order spinal cord dorsal horn neurons (Supplementary 
Figure 1a–c)12–14. Analyses of Fxyd2−/− animals showed that the overall number of sensory neurons was compa-
rable to Fxyd2+/+ littermates (Fig. 1a), and that the proportion of the total DRG neuron subtypes that were found 
to be TrkA+ , TrkB+ , TrkC+ , Ret+ , IB4+ or TH+ was essentially unchanged in the mutants compared to controls 
(Fig. 1b,c). Moreover, electron microscopy analyses also established that the mean numbers of myelinated and 
unmyelinated fibers in the purely sensory saphenous nerve in Fxyd2−/− animals were identical to those found in 
Fxyd2+/+ mice (Fig. 1d–g). Thus, Fxyd2 appears largely dispensable for the differentiation, survival and axonal 
outgrowth of sensory neurons.
To assess putative physiological consequences of Fxyd2 gene deletion, we used ex vivo skin-saphenous nerve 
preparations to analyze the properties of single sensory afferents innervating the skin in C57Bl6 WT animals 
(referred to as WT) and Fxyd2−/− mutant mice. In these experiments, we examined the stimulus response prop-
erties of LTMRs and nociceptors with a series of quantitative stimulus protocols designed to probe the mechano-
sensitivity of skin afferents (see Methods and below)15,16. A summary of the receptor subtypes recorded in WT 
and Fxyd2−/− mutants is shown in Supplementary Table 1. First, LTMRs with Aβ - or Aδ -fiber axons innervating 
hair follicle or Merkel cells in the skin were examined using a series of constant amplitude ramp and hold stim-
uli in which the speed of the ramp was systematically increased from 100 μ m/s to 1000 μ m/s. In WT, the firing 
rate of both rapidly-adapting (RAMs) or slowly-adapting (SAMs) Aβ -fiber LTMRs increased with velocity, and 
this was also true for RAMs and SAMs recorded from Fxyd2−/− mice (Supplementary Figure 2a,c). We also 
measured mechanical latencies for each stimulus strength, a sensitive measure of the activation threshold17, and 
no differences in mechanical latency plots were detected between RAMs or SAMs of WT and Fxyd2−/− mice 
(Supplementary Figure 2b,d). We also found that loss of Fxyd2 did not significantly affect the conduction velocity 
of RAMs and SAMs (Supplementary Figure 2e). These data thus indicate that loss of Fxyd2 activity does not lead 
to any quantitative impairment in the response properties of RAMs and SAMs, consistent with the fact that Fxyd2 
is not normally detected in these two populations.
In contrast, D-Hair receptors with Aδ -fiber conduction velocities, representing the most sensitive LTMR pop-
ulation in the skin18,19, were found to exhibit impaired stimulus-response properties in Fxyd2−/− mutants. Indeed, 
their sensitivity to moving stimuli had a tendency to be decreased at 4 (out of 5) stimulus velocities tested in 
Fxyd2−/− mutants compared to WT, and this was statistically significant for two of them (Fig. 2a). In the same 
line, mechanical latency for mutant D-Hair receptors was increased at 4 (out of 5) stimulus strengths and this 
was statistically significant for the first two slowest stimuli (Fig. 2b). Qualitatively, D-Hair receptors in Fxyd2−/− 
mutant mice had stimulus-response properties that were strikingly similar to RAMs which normally have a sub-
stantially lower sensitivity, especially to slow moving stimuli (Fig. 2c). Interestingly, the mean conduction velocity 
of D-Hair receptors was also found to be increased in Fxyd2−/− mutants (CV = 6.8 ± 0.77 m/s) compared to WT 
(CV = 3.8 ± 0.46 m/s) (Fig. 2d), but remained nevertheless lower than the mean conduction velocity of RAMs 
(13.05 ± 0.45 m/s) (Fig. 2d, Supplementary Table 1). Thus altogether, these data show that loss of Fxyd2 function 
alters the electrophysiological properties of D-Hair receptors which acquire stimulus-response functions more 
typical, albeit not identical, to RAMs. Moreover, the fact that the proportion of Aδ -fibers found with a mechano-
receptor function was unchanged in Fxyd2−/− mutant mice (Supplementary Table 1; Supplementary Figure 2f), 
suggests that Fxyd2 acts autonomously in this neuronal population.
We also tested the function of thinly myelinated Aδ -fiber mechanonociceptors (A-Ms) in Fxyd2−/− mice but 
found little change in their mechanosensitivity compared to controls. There was a very slight increase in the 
mechanical threshold for activation of Fxyd2−/− A-M fibers but this had little or no impact on their firing fre-
quency, mechanical latency or conduction velocity (Supplementary Figure 2e,g,h).
We next assessed the physiological properties of C-fiber nociceptive neurons which encompass the Fxyd2+ /
IB4+ population. Interestingly, in the absence of Fyxd2, we found that the mechanosensitivity to suprathreshold 
stimuli (> 50 μ m) of all C-fibers recorded was significantly enhanced compared to controls (Fig. 3a). In contrast, 
there were no substantial differences in the mean threshold for C-fiber activation or in their response to smaller 
stimuli (< 50 μ m) between the genotypes. The majority of C-fibers, including part of the IB4+ population20, have 
been reported to be polymodal since they respond to both mechanical and noxious heat stimuli and can be clas-
sified as C-mechano-heat nociceptors (C-MHs), while the remaining mechanosensitive C-fibers not responding 
to noxious heat are referred to as C-mechanonociceptors (C-Ms)21,22. Strikingly, we found that the proportion of 
fibers classified as C-Ms or C-MHs was substantially shifted in Fxyd2−/− mice. Indeed, while in control animals 
C-MHs and C-Ms represented, respectively, 64% and 36% of the overall C-fiber population, in Fxyd2−/− mice 
C-Ms represented 67% and C-MHs only 33% (Fig. 3b and Supplementary Table 1). By analyzing the mutant 
C-Ms population which include new afferents that in WT would be normally also sensitive to noxious heat, 
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we found that on average their firing frequencies and mechanical latency were indistinguishable from control 
C-Ms (Fig. 3c; Supplementary Figure 3a), and were thus clearly distinct from C-MHs (Fig. 3d; Supplementary 
Figure 3b). We also found that the population of fibers classified as C-MHs recorded from Fxyd2−/− mice, albeit 
reduced in number, did not show any deficits either in their firing frequency (Fig. 3d), their mechanical latency 
(Supplementary Figure 3b), or in their mean firing rates to standard heat stimuli (ramp 1 °C/s, range 32–48 °C; 
Supplementary Figure 3c) compared to WT C-MHs. Since no neuronal loss was observed in Fxyd2−/− animals 
(see Fig. 1a,b), these findings strongly suggest that a proportion of mutant C-MH fibers loses thermal sensitiv-
ity and becomes more sensitive to mechanical stimulation with characteristics of WT C-M fibers (Fig. 3b–d). 
Interestingly, C-M fibers in the saphenous nerve fire action potentials with frequencies twice as high as C-MH 
fibers in response to supra-threshold mechanical stimuli (compare Fig. 3c,d)17. Since in Fxyd2−/− animals there 
is an increase in the proportion of nociceptors with C-M properties, this result certainly explains the enhanced 
sensitivity of the overall C-fiber population to mechanical stimuli observed in mutants (Fig. 3a).
These findings establishing a role for Fxyd2 in maintaining the normal stimulus-response properties of 
Aδ -fiber D-Hair LTMRs and of sub-populations of C-fiber nociceptors, prompted us to test for behavioral 
Figure 1. Molecular and anatomical analysis of Fxyd2−/− mutant DRG and nerves. (a) Relative 
quantification of total numbers of neurons expressing the pan-neuronal marker SCG10 in adult lumbar DRG of 
Fxyd2+/+ (+ /+ ) and Fxyd2−/− (−/−) animals (n = 3). (b) Comparative analysis of the distribution of sensory 
neuron subtypes expressing TrkA, TrkB, TrkC, Ret, IB4 or TH in Fxyd2+/+ and Fxyd2−/− lumbar DRG (n = 3). 
(c) Representative images of in situ hybridization experiments using TrkA, TrkB, TrkC, Ret, or TH as probes 
and IB4 staining on cryosections of Fxyd2+/+ and Fxyd2−/− lumbar DRG. Bar, 100 μ m. (d,e) Representative 
electron microscopy images of the saphenous nerve from Fxyd2+/+ (d) and Fxyd2−/− (e) mice showing 
myelinated (M) and unmyelinated (U) fibers. Bar, 1 μ m. (f,g) Relative quantification of numbers of myelinated 
(f) and unmyelinated (g) fibers in the saphenous nerve of Fxyd2+/+ (+ /+ ) and Fxyd2−/− (−/−) animals (n = 3), 
revealing no significant difference. In (a,b,f and g), data are represented as mean ± SEM. Statistical analyses 
were performed using Unpaired Student’s t test.
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impairments in Fxyd2−/− mice, notably in response to mechanical and thermal stimuli. We first determined 
that Fxyd2−/− mice exhibited normal locomotor coordination, as illustrated by their normal performance in 
the rotarod test (Supplementary Figure 4a). Next, we assessed their mechanical and thermal reflex sensitivity by 
using von Frey hairs and the Hargreaves test, respectively. However, in agreement with recent findings13, Fxyd2−/− 
animals did not exhibit obvious impaired behavioral responses (Supplementary Figure 4b,c), thus suggesting 
that changes observed in single fiber recordings are either too subtle to be detected at the behavioral level or are 
functionally compensated.
We nevertheless reasoned that functional consequences of Fxyd2 gene deletion in sensory neurons might be 
exacerbated in the context of a challenged somatosensory system. We thus subjected Fxyd2−/− and Fxyd2+/+ mice 
to the spared nerve injury (SNI) model of peripheral neuropathic pain in which the tibial and common pero-
neal nerves are lesioned, while the sural nerve is left intact23. First, since we have reported that Fxyd2 was durably 
down-regulated in sensory neurons after complete axotomy of the sciatic nerve12, we assessed its expression in the 
SNI model. In contrast to axotomy, Fxyd2 expression was found to remain largely intact over time after SNI, though 
a slight and transient decreased was observed 4 days after surgery (Fig. 4a). This observation thus validated the use 
of the SNI model for behavioral analyses. By assessing paw withdrawal thresholds with calibrated von Frey hairs, we 
observed that both SNI-Fxyd2+/+ and SNI-Fxyd2−/− mice rapidly displayed comparable mechanical allodynia. In 
SNI-Fxyd2+/+ mice, mechanical pain hypersensitivity was maintained at least 28 days following surgery. In contrast, 
in SNI-Fxyd2−/− animals paw withdrawal thresholds started to progressively approach values found in uninjured 
animals beginning around day 7 post-injury (Fig. 4b). These results thus indicate that Fxyd2 is selectively involved 
in the maintenance of chronic mechanical hypersensitivity induced by peripheral nerve lesions.
Figure 2. Impaired response properties of Aδ-fiber LTMRs in Fxyd2−/− mutants revealed by single fiber 
recordings on skin-saphenous nerve preparations. (a,b,c) Receptive field properties of single cutaneous 
afferents after application of a series of ramp and hold stimuli with increasing velocities (0.075, 0.15, 0.45, 1.5 
and 4.5 mm/s at 92 μ m displacements) are shown for D-Hairs Aδ -fiber LTMRs (a–c) and RAMs (c) in WT 
and for D-Hairs Aδ -fiber LTMRs (a–c) in Fxyd2−/− mice. Mean firing frequencies during the ramp phase of 
D-Hairs and RAMs (a,c) or mechanical latencies of D-Hairs (b) were plotted as function of stimulus velocity. 
Insets in (a) shows an illustrative examples of recordings from WT and Fxyd2−/− animals, insets in (b) shows 
the proportion of fibers responding to each stimulus. (d) Action potential conduction velocities (CV) of 
D-Hairs from WT and Fxyd2−/− mutants and of RAMs from WT are displayed. Note that mutant D-Hairs 
show untypical fast conduction properties that significantly differ from controls, though without reaching the 
CV of RAMs. Data are represented as mean ± SEM; numbers indicate fibers recorded. Statistical analyses were 
performed by Two-way ANOVA with Bonferoni post-hoc test in (a,b) and Mann-Whitney U test in  
(d); *P < 0.05; **P < 0.01; ***P < 0.001.
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In order to provide insights into how Fxyd2 loss may trigger this effect, we focused on IB4+ C-fiber nocic-
eptors. Indeed, these neurons are Fxyd2+ , are easily identifiable in vitro for electrophysiological recordings20, 
are functionally modified after SNI8 and have been previously implicated in injury-induced pain7,24–26. We first 
assessed the excitability properties of this neuronal population from uninjured WT and Fxyd2−/− animals, using 
whole cell patch clamp recordings in vitro. Under control conditions, 500 ms step increases in current injection 
evoked a progressive increase in action potential burst frequency and no significant difference in current evoked 
spikes were observed between WT and Fxyd2−/− neurons (Fig. 4c–e). This absence of excitability changes of 
mutant IB4+ cell bodies contrasted with the altered response of C-fiber subtypes following natural stimulation 
of their receptor fields, supporting the view that Fxyd2 mainly acts in the periphery. These data also raise the 
possibility that it is differences in the mechanotransduction apparatus and not electrical excitability that underlies 
the different receptor properties of C-M and C-MH fibers. In contrast, after SNI, the number of spikes evoked 
in SNI-Fxyd2−/− IB4+ neurons was strikingly significantly lower than in SNI-WT neurons (Fig. 4d,f) thus illus-
trating the implication of Fxyd2 in the electrophysiological changes occurring after peripheral nerve lesions. 
These findings are reminiscent of the role of Fxyd2 in modulating the activity of the Na,K-ATPase pump after 
inflammation13. Thus beneficial outcomes of constitutive Fxyd2 gene deletion on neuropathic pain symptoms 
correlate with altered excitability of sensitized IB4+ non-peptidergic nociceptors. However, beyond the clear elec-
trophysiological alterations of this neuronal population under SNI conditions, it is not totally excluded that other 
Fxyd2+ neurons might also be involved. In particular, indirect evidence has suggested that TH+ C-LTMRs27 
may participate in the process of neuropathic pain28, although this issue is still controversial29,30. Also, under 
SNI conditions normally innocuous mechanical stimuli provoke paw withdrawal, and the absolute magnitude 
of the stimuli that are apparently painful in such circumstances would efficiently activate LTMRs22, but not most 
Figure 3. Impaired response properties of C-fiber nociceptor subtypes in Fxyd2−/− mutants. (a) An 
ascending series of displacements (16–512 μ m) using a constant stimulus velocity were used to mechanically 
stimulate C-fibers from WT and Fxyd2−/− mice. Mean firing frequencies were plotted as function of 
displacement amplitudes. Note that globally, mutant C-fibers are significantly more sensitive to suprathreshold 
mechanical stimuli compared to controls. (b) Distribution of C-M and C-MH fibers recorded in WT and 
Fxyd2−/− animals. The proportion of C-M vs C-MH was significantly increased in Fxyd2−/− mice (36% in 
Fxyd2+/+ vs 67% in mutants). (c,d) An ascending series of displacements (16–512 μ m) using a constant 
stimulus velocity were used to mechanically stimulate C-fibers identified as C-Ms (g) or C-MHs (h) from WT 
and Fxyd2−/− mice. Mean firing frequencies were plotted as function of displacement amplitudes. Data are 
represented as mean ± SEM; numbers indicate fibers recorded. Statistical analyses were performed by Two-
way ANOVA with Bonferoni post-hoc test in (a,c,d) and Chi-squared test in (b). ns: not significant; *P < 0.05; 
**P < 0.01; ***P < 0.001.
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mechanosensitive C-fiber nociceptors8. We have shown that loss of Fxyd2 function triggers a radical reduction in 
the sensitivity of D-Hair receptors that are normally the most sensitive mechanoreceptor sub-class (Fig. 2a,b)19. 
Figure 4. Reduced neuropathic pain in spared nerve injury-Fxyd2−/− mice correlates with altered 
excitability of sensitized mutant IB4+ C-nociceptors. (a) RT-qPCR analysis of Atf3 and Fxyd2 on lumbar DRG 
samples from naive (N) and SNI-animals harvested between 4 and 28 days after surgery. Specific expression 
of Atf3 in DRG of SNI-mice attests to their injured state. At day 4 post-SNI a slight dip in Fxyd2 expression 
is observed, although levels returned to normal by day 7 and subsequently (n = 3 replicates). (b) Analysis of 
mechanical sensitivity assessed by the von Frey “up and down” method in Fxyd2+/+ (n = 12) and Fxyd2−/− 
(n = 12) mice before and up to 28 days after SNI, showing selective reduction of mechanical allodynia in 
mutants. (c,d) Representative traces of repetitive firing elicited by 500 ms depolarizing current injection of 1 nA 
in IB4+ nociceptors from naive WT or Fxyd2−/− (c) and SNI-WT or SNI-Fxyd2−/− mice 17 days post-surgery 
(d). (e,f) Quantitative analyses of the firing frequency of IB4+ nociceptors from naive WT and Fxyd2−/− animals 
(e) and of sensitized IB4+ neurons from SNI-WT and SNI-Fxyd2−/− mice (f) after progressive increase of 
current intensity from 0.2 to 1.2 nA, showing selective altered excitability in SNI-Fxyd2−/− animals (n = at least 
10 from three distinct animals). Data are represented as mean ± SEM. Statistics were performed by one-way 
ANOVA and Newman-Keuls post-hoc test in (a) and by two-way ANOVA and Bonferroni post-hoc test in 
(b,e,f): *P < 0.05; **P < 0.01; ***P < 0.001; n.s., not significant.
www.nature.com/scientificreports/
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It is thus possible that allodynia might be partly also driven by activation of D-Hair receptors, but the reduction 
in their activation in Fxyd2−/− mutants may lead to the partial alleviation of allodynia especially late in the time 
course of the SNI-induced hypersensitivity.
Intriguingly, the selective requirement of Fxyd2 for the maintenance of a chronic pain state, being of inflam-
matory13 or of neuropathic origin (this study), contrasts with the apparently normal behavior of mutant mice 
under healthy conditions (Supplementary Figure 4)13. This suggests that Fxyd2 constitutes a key determinant 
whose function is mainly engaged post-injury and raises the possibility that targeted inhibition of its activity 
and/or expression may represent a strategy to manage neuropathic pain symptoms in a clinical setting. As a 
prerequisite to test this issue, we assessed whether FXYD2 expression was conserved in human DRG. First, by 
RT-qPCR analyses on human cDNA samples prepared from fibroblasts or lumbar DRG, we observed that FXYD2 
was present at high levels specifically in the DRG (Fig. 5a). In addition, by performing immunohistochemistry on 
human lumbar DRG sections, we found that FXYD2 was strikingly detected in subpopulations of sensory neu-
rons of small- and medium-diameters representing about 45% of the entire DRG neuronal population (Fig. 5b) 
consistent with what was observed in rodents. Therefore, these results show that FXYD2 expression in primary 
sensory neuron subtypes is conserved between mouse and man.
Next, to begin to explore the therapeutic potential of blocking Fxyd2 function in vivo, we tested whether 
acute intrathecal injections of Fxyd2-siRNA into the sub-arachnoid space in SNI-rats, after the establishment 
of a chronic pain state, might have beneficial impacts. We took advantage of the fact that the sub-arachnoid 
space is contiguous with the dorsal roots such that siRNA diffuses into the DRG and penetrates into the sensory 
neurons31. Using this approach, we determined that daily in vivo administration of Fxyd2-siRNA during 5 days 
led to a 60% reduction in numbers of Fxyd2+ neurons in the DRG compared to injection of control-siRNAs 
(Fig. 5c–e). We thus carried out behavioral analyses on neuropathic rats by studying their responses to noxious 
mechanical stimulations. Using the modified Randall-Selitto test32 based on vocalization behavior, we found that 
SNI-rats exhibited persistent mechanical hyperalgesia, and that injections of control-siRNA had no effect on 
the pathological symptoms over time. In contrast, intrathecal Fxyd2-siRNA injections significantly alleviated 
SNI-induced mechanical pain hypersensitivity in these animals starting 3 days after the first injection and contin-
uing subsequently (Fig. 5f). Similar results were obtained by analyzing mechanical allodynia using the von Frey 
test (Supplementary Figure 4d). These data thus show that acute inhibition of Fxyd2 expression has beneficial 
effects on neuropathic pain symptoms, thus providing the proof of concept for its therapeutic relevance.
In conclusion, these data reveal novel roles for the Fxyd2 protein in setting the mechanosensitivity of Aδ -fiber 
D-Hair receptors and of a sub-population of C-fiber nociceptors. They also extend previous findings by establish-
ing that under pathological conditions, loss of Fxyd2 either constitutively in Fxyd2−/− mutant mice or acutely by 
intrathecal injections of siRNA in rats, efficiently alleviates neuropathic pain induced by peripheral nerve lesions. 
Since loss of Fxyd2 function appears compatible with normal physiology and since this protein is not expressed in 
spinal neurons, it is likely that the protective effects of blocking Fxyd2 function against peripheral lesion-induced 
pain reflect changes in the basal sensitivity of injury-induced excitability of IB4+ nociceptors, but also possibly 
of D-Hair mechanoreceptors. Finally, the fact that the expression of FXYD2 protein appears conserved in human 
DRG suggests that it could be an interesting therapeutic target for neuropathic pain management.
Materials and Methods
Animals and Surgery. All experiments were approved by the Direction Départementale des Services 
Vétérinaires de l’Hérault (Certificate of Animal Experimentation n° 34–376, 17 February 2009) and performed 
according to the guidelines of the International Association for the Study of Pain (IASP). Fxyd2−/− mice11 were 
maintained on a C57Bl6 background. For molecular, histological and behavioral analyses on mice, wild type lit-
termates (referred to as Fxyd2+/+) were used. Wild-type C57Bl6 animals (referred to as WT) were used as controls 
for single neuron recordings (obtained from Janvier) or ex vivo skin-nerve preparations (obtained from Charles 
Rivers). All animals were housed with a 12/12 dark/light cycle and ad libitum access to water and food. Five week-
old male Sprague-Dawley rats (Janvier), weighing 200 to 250 g at the beginning of the experiments, were used. 
Unilateral Spared Nerve Injury (SNI) surgery23 was performed on animals which were deeply anesthetized with 
Ketamine-Xylasine (respectively 100 mg/kg and 10 mg/kg). Briefly, the left hindlimb was immobilized in a lateral 
position and slightly elevated. Skin incision was made at mid-thigh level using the femur as a landmark, and 
muscle layers were separated to bring out the sciatic nerve and its three branches (sural, common peroneal, and 
tibial nerves). Both tibial and common peroneal nerves were tightly ligated with a 6.0 silk thread (Ethicon), tran-
sected together and a 1–2 mm section of the two nerves was removed. The sural branch was carefully preserved 
by avoiding any nerve stretch or contact with surgical tools. The muscle layer was closed by careful apposition and 
skin sutured with vicryl 4.0 threads. A subcutaneous injection of NaCl 0.9% (10 ml/kg) was finally performed to 
prevent for dehydration. Note that rats in the sham group had their sciatic nerve exposed as in the SNI procedure, 
but they received no further manipulations.
Ex vivo skin-nerve preparations. Skin-nerve preparations to record from single primary afferents were 
performed as previously described17. Mice were killed by CO2 inhalation for 2–4 min followed by cervical dis-
location. The saphenous nerve and the skin of the hind limb were dissected and placed in an organ bath. The 
chamber was perfused with a synthetic interstitial fluid (SIF buffer: NaCl, 123 mM; KCl, 3.5 mM; MgSO4, 0.7 mM; 
NaH2PO4, 1.7 mM; CaCl2, 2 mM; sodium gluconate, 9.5 mM; glucose, 5.5 mM; sucrose, 7.5 mM; and HEPES, 
10 mM at a pH of 7.4). The skin was placed with the corium side up in the organ bath. The nerve was placed in 
an adjacent chamber on a mirror to aid fiber teasing under a stereomicroscope. Fine filaments were teased from 
the saphenous nerve and placed on the recording electrode. Electrical isolation was achieved with mineral oil. 
Mechanical sensitivity of single units was tested by mechanical stimulation with a glass rod. Mechanically-evoked 
spikes were visualized and the template saved in an oscilloscope. Then, a sharp tungsten metal electrode was 
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Figure 5. Conserved restricted expression of FXYD2 in human DRG and alleviation of mechanical pain 
hypersensitivity in neuropathic rats by acute intrathecal injections of Fxyd2-siRNA. (a) RT-qPCR analysis 
of FXYD2 expression on human fibroblasts and human DRG samples revealing specific detection of FXYD2 in 
the DRG (n = 3 replicates). (b) Immunohistochemistry on human lumbar DRG transverse sections using an 
anti-FXYD2 antibody. FXYD2 is detected in subpopulations of sensory neurons of small- (black arrows) and 
medium-diameters (black arrowheads). Green arrows and arrowheads point to FXYD2-negative small and large 
diameter neurons, respectively. (c,d) Representative images of immunofluorescent staining using an anti-Fxyd2 
antibody on transverse DRG sections from SNI-rats 16 days post-surgery, that were subjected to daily injections 
of control-siRNA (c) or Fxyd2-siRNA (d) from days 11 to 15, illustrating reduced numbers of Fxyd2+ neurons 
selectively in Fxyd2-siRNA-injected animals. (e) Relative quantification of Fxyd2+ sensory neurons in lumbar 
DRG from control-siRNA-injected (n = 3) and Fxyd2-siRNA-injected SNI-rats (n = 3) 16 days post-surgery, 
that were subjected to daily injections of control- (c) or Fxyd2-siRNAs (d) from days 11 to 15, revealing a 60% 
reduction in Fxyd2-siRNA-injected animals. (f) Behavioral analyses using the Randall-Selitto test on Sham-rats 
(n = 6, black curve with circles) and SNI-rats injected either with control- (n = 6, black curve with triangles) or 
Fxyd2-siRNA (n = 6, grey curve with squares) after the establishment of chronic pain, showing selective pain 
alleviation by Fxyd2-siRNA injections. Data are represented ± SEM. Statistics were performed by Unpaired 
Student’s t test in (e) and two-way ANOVA and Bonferroni post-hoc test in (f); n.d., not detected; *P < 0.05; 
***P < 0.001. Bars, 100 μ m.
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placed in the receptive field and an electrically evoked spike was elicited with suprathreshold current pulses 
and the electrical latency, the time from the stimulation artifact to spike, was recorded. The distance between 
the stimulating and recording electrode was designated as the conduction distance. For each isolated fiber the 
conduction velocity was calculated by dividing conduction distance over electrical latency for the spike. A 
computer-controlled nanomotor (Kleindiek, Reutlingen, Germany) was used to apply controlled displacement 
stimuli of known amplitude and velocity. The probe was a stainless steel metal rod and the diameter of the flat cir-
cular contact area was 0.8 mm containing a force transducer (Kleindiek, Reutlingen, Germany). The signal driv-
ing the movement of the linear motor and raw electrophysiological data were collected with a Powerlab 4.0 system 
(ADInstruments) and spikes were discriminated off-line with the spike histogram extension of the software.
Behavioral testing on mice. Locomotor coordination was evaluated with a rotarod accelerating procedure 
(0–16 rpm for 3 min) and the latency to fall was measured. Thermal sensitivity was determined blindly using the 
Hargreaves test33. Briefly, a radiant heat source (a high-intensity projector lamp) was focused onto the plantar sur-
face of the paw and paw-withdrawal latency was determined. Each paw was tested 3 times with a 10 min interval 
between each trial, and a maximal cut-off time of 20 s was used to prevent tissue damage. Mechanical sensitivity 
on mice was assessed blindly by placing animals on an elevated wire mesh grid and stimulating the hind paw with 
von Frey hairs by using the “up and down” paradigm34. The left hind paw was tested twice at 30 min intervals. 
The schedule of the experiment was as follows: after testing for baseline mechanical sensitivity on two occasions 
separated by at least 24 h, mice were subjected to SNI surgery. Note that, as this model spared the sural territory, 
von Frey stimuli were performed on the lateral aspect of the hind paw during the baseline and post-operative 
measurements. Mice were tested on postoperative days 4, 7, 14 and 28. Experiments were performed on six males 
and six females for each genotype. No significant difference was observed between genders.
Intrathecal siRNA injections in rats. An “ON-TARGET plus” siRNA directed against the rat Fxyd2 mRNA 
was purchased from Dharmacon. The sense sequence was as follows: 5′ -AAUCCCUUCGAGUAUGAUUU-3′ 35. 
The siGENOME Non-targeting siRNA #2 (Dharmacon, D-001210-02-20) was used as a negative control. 
SNI-operated rats were daily intrathecally injected from day 11 to 15 after surgery under brief isoflurane anesthe-
sia with 2 μ g of control- or Fxyd2-siRNA in Exgen transfection reagent (Euromedex, ET0250) in a volume of 20 μ l. 
The transfection mix was prepared as follows: 10 μ l of siRNA solution containing 50 μ g was mixed with 240 μ l of 
5% glucose solution in water. Exgen500 transfection reagent (9 μ l) was separately added to 241 μ l of glucose solu-
tion and mixed. After combining the 2 solutions, they were mixed and then left for 10 min at room temperature 
before injections into the sub-arachnoid space31.
Behavioral testing on rats. Sprague-Dawley rat males were housed three per cage under standard condi-
tions of light and temperature. Commercial chow pellets and tap water were available ad libitum. After arrival, 
animals were left to become accustomed to the colony room for 4 days. To avoid stress resulting from the exper-
imental conditions, analyses were performed by the same experimenter in quiet conditions in a test room close 
to the colony room. For 2 weeks before the experiments, animals were weighed daily, handled gently for 5 min, 
and placed in the test room for 1 h, where they were left to become accustomed to the nociceptive apparatus. 
Mechanical allodynia and mechanical hyperalgesia were evaluated the day before and the day of surgery (d-1 and 
d0) and once daily after surgery. For mechanical allodynia, we performed the von Frey test, as described above for 
mice, on four animals for each experimental condition. For mechanical hyperalgesia, nociceptive thresholds in 
handheld rats were determined with the paw-pressure vocalization test as previously described32 on six animals 
for each experimental condition. Briefly, a constantly increasing pressure was applied to the injured hind paw 
until the rat squeaks. The Basile analgesimeter (Apelex; stylus tip diameter, 1 mm) was used. A 600 g cutoff value 
was determined to prevent tissue damage.
Real-time qPCR. Lumbar DRG (L4–L6) from naive and SNI-mice at different days post-surgery (4, 7, 14 and 28) 
were dissected and stored at − 80 °C until RNA was extracted using the RNAqueous-4PCR Kit (Ambion). 1 μ g 
of total RNA from mouse DRG, from human DRG (Clontech, Lot number 1105216A) or from human fibro-
blasts (provided by Dr. C. Angebault-Prouteau) were reverse-transcribed with 100 U of Superscript II reverse 
transcriptase (Invitrogen) and 5 μ M hexamer random primers (Boehringer Mannheim), 0,5 mM of each dNTPs 
(Pharmacia), 10 mM of dithiothreitol and 20 U of recombinant RNase inhibitor (Promega) for 1 hour at 37 °C 
and then stored at –80 °C until use. Real time PCR was carried out as described previously36 using SYBR Green 
I dye detection on the LightCycler system (Roche Molecular Biochemichals). PCR reactions were performed 
in 96 well plates in a 10 μ l volume containing 3 μ l of RT product (final dilution 1/30), 0.5 μ M of forward and 
reverse primers, and 2 μ l of QuantiTect SYBR Green PCR Master Mix (Roche Diagnosis). Amplified products 
were sequenced at least once (Beckman Coulter Genomics, UK). The relative amounts of specifically ampli-
fied cDNAs were calculated using the delta-CT method37,38 on three independent experimental replicates and 
normalized by dividing with an appropriate normalization factor. For mice samples, this factor was the geomet-
ric mean of two stable control genes: polymerase (RNA) II polypeptide J (Polr2j) and DEAD box polypeptide 
48 (Ddx48). Beta actin (ACTB) was used for human samples. Sequences of the primer pairs were as follows: 
Polr2j (GenBank:NM_011293): F-ACCACACTCTGGGGAACATC, R-CTCGCTGATGAGGTCTGTGA; 
Ddx48 (GenBank:NM_138669): F-GGAGTTAGCGGTGCAGATTC, R-AGCATCTTGATAGCCCGTGT; Atf3 
(Genbank: NM_007498): F-ACAACAGACCCCTGGAGATG, R-CCTTCAGCTCAGCATTCACA; mouse Fxyd2 
(Genbank: NM_007503, NM_052823): F-GGACAGAGAATCCCTTCGAG, R-CCGATTTCATTGGCAGTTG; 
ACTB (Genbank: NM_001101.3): F-GCACTCTTCCAGCCTTCCTT-; R- GTTGGCGTACAGGTCTTTGC; 
Human FXYD2 (GenBank:NM_001680) primers were purchased from Clinisciences (HP205498).
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In situ hybridization, double in situ hybridization and immunohistochemistry. Simple and dou-
ble in situ hybridization were performed as previously described12. Digoxigenin (DIG)- or Fluorescein-labeled 
antisense RNA probes were synthesized using the DIG- or Fluorescein-labelling kit (Roche), respectively. Fxyd2, 
Ret, SCG10, TrkA, TrkB, TrkC, and TH probes were used in this study. Immunofluorescent and isolectin-B4 stain-
ing were performed as previously described12. Rabbit anti-C-terminal Fxyd2 antibody (provided by Dr. S. Karlish, 
diluted 1:2000) and Alexa Fluor-594-conjugated secondary antibody were used (Molecular Probes, diluted 
1:2000). Human lumbar DRG were collected through the “Coordination Hospitalière de Prélèvement et Agence 
de Biomédecine” and harvested according to the French Biomedical Agency guidelines, from two brain-dead 
adult patients who were organ donors, as previously reported39. Immunohistochemistry was performed using a 
mouse anti-FXYD2 antibody (Abnova, H00000486-M01) and the Vectastain ABC kit (Vector).
Cell counting. Numbers of neurons expressing the various molecular markers of sensory neuron subtypes 
in Fxyd2+/+ and Fxyd2−/− littermates, and Fxyd2+ neurons in SNI-operated rats injected either with control- or 
Fxyd2-siRNA were determined by counting cells with neuronal morphology and clearly identifiable nuclei. A 
minimum of six sections from lumbar DRG were counted from at least three independent animals for each gen-
otype or conditions. The percentage of neurons expressing a given marker either over the total number of DRG 
neurons, or over the total number of a defined population, was calculated.
Electron microscopy. Saphenous nerves from Fxyd2+/+ and Fxyd2−/− littermates were dissected out and 
immersed in a solution of 2.5% glutaraldehyde in PHEM buffer (pH 7.4) overnight at 4 °C. They were then washed 
in PHEM buffer and post-fixed in a 0.5% osmic acid + 0.8% potassium ferrocyanide solution for 2 h at room tem-
perature in the dark. After two washes with PHEM buffer, samples were dehydrated with solutions of increasing 
ethanol concentration (30–100%). Samples were embedded in EmBed 812 using an Automated Microwave Tissue 
Processor for Electronic Microscopy (Leica EM AMW). Thin sections (70 nm; Leica-Reichert Ultracut E) were 
collected, counterstained with uranyl acetate and lead citrate and observed using a Hitachi 7100 transmission 
electron microscope. Myelinated and unmyelinated fibers were counted on the saphenous nerves from three 
Fxyd2+/+ and Fxyd2−/− animals.
Mouse DRG neuron isolation and electrophysiological recordings. Naïve or SNI WT and Fxyd2−/− 
mice were killed by CO2 inhalation followed by cervical dislocation and their dorsal root ganglia were harvested. 
Neuronal cultures were established from L4-L6 lumbar dorsal root ganglia as previously reported40. For identifi-
cation of IB4+ neurons, cultures were incubated at 37 °C for 10 min with 10 μ g/ml IB4-FITC (Sigma) and washed 
twice 5 min with the bathing solution used for electrical activity recording. After SNI, non-injured sensitized 
IB4+ neurons were identified on morphological criteria including absence of regenerative axonal growth. Action 
potentials in dorsal root ganglion neurons were recorded with the whole-cell patch-clamp technique after 1 day 
in vitro, at 20–22 °C. Recordings were performed on at least 10 neurons for each condition, on at least three 
independent animals. The bathing solution contained NaCl, 140 mM; KCl, 5 mM; CaCl2, 2 mM; MgCl2, 1.5 mM; 
HEPES, 10 mM; glucose, 10 mM and the pH was adjusted to 7.4 with NaOH. Recording pipettes (3–4 MΩ ) were 
filled with the following solution: KCl, 140 mM; HEPES, 10 mM; Mg-ATP, 2 mM; Na2-GTP, 0.5 mM; EGTA, 
10 mM; pH 7.35, adjusted with KOH. Signals were filtered at 5 kHz and sampled at 10 kHz. Whole-cell recordings 
were obtained with an Axopatch 200B amplifier (Axon Instruments). The experimental parameters were con-
trolled with a computer equipped with a Digidata 1322 analogue interface (Axon Instrument). We used pClamp 
software (Clampex 8.02 and 9.2; Axon Instruments) for data acquisition and analysis, respectively. Following 
patch membrane disruption for whole-cell recordings, only IB4+ neurons displaying membrane resistance above 
150 MΩ were selected (300 ± 22 MΩ , n = 39). To analyze the frequency-current relationships, a 500 ms current 
with increasing intensities from 0.2 to 1.2 nA was injected into the neuron.
Statistical analyses. For cell counting, statistical analyses were performed using Unpaired Student’s 
t test. For RT-qPCR experiments, one-way analysis of variance (ANOVA) was used followed by a post-hoc 
Newman-Keuls test. For behavioral studies, group and time effects were validated by two-way ANOVAs for 
repeated measurements. When ANOVAs showed a significant effect, Bonferroni post-hoc test was used to deter-
mine the significance of the differences. For electrophysiological analyses, data were analyzed using a two-way 
ANOVA, followed by Bonferroni test. Fiber conduction velocities were analyzed using the Mann-Whitney U test. 
Fiber type distribution was analyzed using the Chi-squared test. P values < 0.05 were considered as statistically 
significant. All data presented are means ± SEM.
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